Literature DB >> 35388667

Implanted System for Orthostatic Hypotension in Multiple-System Atrophy.

Jordan W Squair1, Maxime Berney1, Mayte Castro Jimenez1, Nicolas Hankov1, Robin Demesmaeker1, Suje Amir1, Aurelie Paley1, Sergio Hernandez-Charpak1, Gregory Dumont1, Leonie Asboth1, Gilles Allenbach1, Fabio Becce1, Patrick Schoettker1, Gregoire Wuerzner1, Julien F Bally1, Grégoire Courtine1, Jocelyne Bloch1.   

Abstract

Orthostatic hypotension is a cardinal feature of multiple-system atrophy. The upright posture provokes syncopal episodes that prevent patients from standing and walking for more than brief periods. We implanted a system to restore regulation of blood pressure and enable a patient with multiple-system atrophy to stand and walk after having lost these abilities because of orthostatic hypotension. This system involved epidural electrical stimulation delivered over the thoracic spinal cord with accelerometers that detected changes in body position. (Funded by the Defitech Foundation.).
Copyright © 2022 Massachusetts Medical Society.

Entities:  

Mesh:

Year:  2022        PMID: 35388667     DOI: 10.1056/NEJMoa2112809

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   176.079


  3 in total

Review 1.  Multiple system atrophy.

Authors:  Werner Poewe; Iva Stankovic; Glenda Halliday; Wassilios G Meissner; Gregor K Wenning; Maria Teresa Pellecchia; Klaus Seppi; Jose-Alberto Palma; Horacio Kaufmann
Journal:  Nat Rev Dis Primers       Date:  2022-08-25       Impact factor: 65.038

2.  Implantable neurostimulators for neurogenic orthostatic hypotension: the wave of the future? and other updates on recent autonomic research.

Authors:  Mitchell G Miglis; Nicholas Larsen; Srikanth Muppidi
Journal:  Clin Auton Res       Date:  2022-06-03       Impact factor: 5.625

Review 3.  Long-COVID Syndrome and the Cardiovascular System: A Review of Neurocardiologic Effects on Multiple Systems.

Authors:  Nicholas L DePace; Joe Colombo
Journal:  Curr Cardiol Rep       Date:  2022-09-30       Impact factor: 3.955

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.